Dashboard
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -100.00% and Operating profit at 0% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
Flat results in Sep 25
Risky - Negative EBITDA
Stock DNA
Industrial Manufacturing
INR 25 Cr (Micro Cap)
NA (Loss Making)
31
0.00%
-0.57
14.55%
-4.27
Total Returns (Price + Dividend) 
Miven Mach. Tool for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Miven Machine Tools Faces Intense Selling Pressure Amidst Consecutive Losses
Miven Machine Tools Ltd is currently experiencing significant selling pressure, with the stock registering a lower circuit and an absence of buyers in the market. The industrial manufacturing company’s shares have shown consecutive declines, reflecting distress selling signals amid a challenging trading environment.
Read More
Miven Machine Tools Faces Intense Selling Pressure Amidst Consecutive Losses
Miven Machine Tools Ltd is currently experiencing significant selling pressure, with the stock showing no buying interest and a queue dominated solely by sell orders. This distress selling signals a challenging phase for the industrial manufacturing company as it navigates through a period of consecutive losses and subdued market performance.
Read More
Miven Machine Tools Faces Intense Selling Pressure Amidst Consecutive Losses
Miven Machine Tools Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling has contributed to a series of consecutive losses, contrasting sharply with broader market gains and signalling heightened investor caution in the industrial manufacturing sector.
Read More Announcements 
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (LODR) Regulations 2015
30-Jan-2026 | Source : BSEMiven Machine Tools Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve To consider and approve the unaudited financial results of the Company for the third quarter of the financial year 2025-26 ended on 31st December 2025 together with Limited Review Report issued by Statutory Auditors of the Company
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Jan-2026 | Source : BSEKindly take note of Certificate under Reg.74(5) of SEBI DP Regulations for Quarter ended 31 Dec 2025
Closure of Trading Window
30-Dec-2025 | Source : BSEClosure of trading window for the quarter ended on 31-12-2025 for approval of unaudited financials results.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sundeep Reddy Katta (37.5%)
Anil Kumar (2.42%)
21.2%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 11.76% vs -6.25% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs -100.00% in Sep 2024
Growth in half year ended Sep 2025 is 0.00% vs 44.64% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -100.00% vs 212.82% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 58.18% vs -71.88% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -100.00% vs 41.18% in Mar 2024
YoY Growth in year ended Mar 2025 is -117.86% vs -103.79% in Mar 2024